Literature DB >> 15583217

Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: a primary disorder of vascular smooth muscle.

Pei-Xuan Wang1, Paul W Sanders.   

Abstract

The Dahl/Rapp salt-sensitive (S) rat is a model of salt-sensitive hypertension and hypertensive renal disease. This study explored the role of vascular remodeling in the development of renal failure in S rats. Groups of S and Sprague-Dawley rats were given 0.3 and 8.0% NaCl diets for up to 21 days and evidence of smooth muscle proliferation identified using immunohistochemistry that showed nuclear accumulation of proliferating cell nuclear antigen and 5-bromo-2'-deoxy-uridine. Compared with the other three groups, S rats on 8.0% NaCl diet showed increased nuclear labeling of cells of the aorta and arteries and arterioles of the kidney by the end of the first week of study. Progressive luminal narrowing of the interlobular arteries and preglomerular arterioles occurred in S rats over the 3 wk on the 8.0% NaCl diet. Accumulation of pimonidazole adducts and nuclear accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) were used as markers of tissue hypoxia. By the end of the second week of study, pimonidazole levels increased in S rats on 8.0% NaCl diet and deposition was apparent in tubular cells in the cortex and medulla. At the completion of the experiment, HIF-1alpha levels were increased in nuclear extracts from the cortex and medulla of S rats on this diet, compared with the other three groups of rats. The data demonstrated a disorder of the vascular remodeling process with proliferation of vascular smooth muscle cells temporally followed by development of tissue hypoxia in the hypertensive nephropathy of S rats on 8.0% NaCl diet.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15583217     DOI: 10.1152/ajprenal.00213.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

1.  Afferent arteriolopathy and glomerular collapse but not segmental sclerosis induce tubular atrophy in old spontaneously hypertensive rats.

Authors:  Sabine Leh; Michael Hultström; Christian Rosenberger; Bjarne M Iversen
Journal:  Virchows Arch       Date:  2011-06-10       Impact factor: 4.064

2.  Human nephrosclerosis triggers a hypoxia-related glomerulopathy.

Authors:  Matthias A Neusser; Maja T Lindenmeyer; Anton G Moll; Stephan Segerer; Ilka Edenhofer; Kontheari Sen; Daniel P Stiehl; Matthias Kretzler; Hermann-Josef Gröne; Detlef Schlöndorff; Clemens D Cohen
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

3.  Signaling pathways modulated by fish oil in salt-sensitive hypertension.

Authors:  Montserrat M Diaz Encarnacion; Gina M Warner; Catherine E Gray; Jingfei Cheng; Hesham K H Keryakos; Karl A Nath; Joseph P Grande
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-02

Review 4.  Vascular consequences of dietary salt intake.

Authors:  Paul W Sanders
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-01

5.  Avian erythroblastosis virus E26 oncogene homolog-1 (ETS-1) plays a role in renal microvascular pathophysiology in the Dahl salt-sensitive rat.

Authors:  Wenguang Feng; Zhengrong Guan; Dongqi Xing; Xingsheng Li; Wei-Zhong Ying; Colton E Remedies; Edward W Inscho; Paul W Sanders
Journal:  Kidney Int       Date:  2019-10-22       Impact factor: 10.612

6.  Rs884225 polymorphism is associated with primary hypertension by compromising interaction between epithelial growth factor receptor (EGFR) and miR-214.

Authors:  Fang Luo; Yitian Wu; Qunfang Ding; Yiming Yuan; Weiguo Jia
Journal:  J Cell Mol Med       Date:  2021-02-26       Impact factor: 5.310

7.  Quantitative proteomics reveals novel therapeutic and diagnostic markers in hypertension.

Authors:  Vittoria Matafora; Laura Zagato; Mara Ferrandi; Isabella Molinari; Gianpaolo Zerbini; Nunzia Casamassima; Chiara Lanzani; Simona Delli Carpini; Francesco Trepiccione; Paolo Manunta; Angela Bachi; Giovambattista Capasso
Journal:  BBA Clin       Date:  2014-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.